Neutralizing IL-23 is superior to blocking IL-17 in suppressing intestinal inflammation in a spontaneous murine colitis model. (Q41389903)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Neutralizing IL-23 is superior to blocking IL-17 in suppressing intestinal inflammation in a spontaneous murine colitis model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Sumaira Z Hasnain

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

I Das

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Iulia Oancea

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Rajaraman Eri

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Michael A McGuckin

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Hui Tong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Alice Che-Hao Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Martina Proctor

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Timothy H Florin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

1 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

973-984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

Th17 cells in human disease.

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

A protective function for interleukin 17A in T cell-mediated intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

Monoclonal Anti–Interleukin 23 Reverses Active Colitis in a T Cell–Mediated Model in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

Ustekinumab induction and maintenance therapy in refractory Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

Glucocorticoids alleviate intestinal ER stress by enhancing protein folding and degradation of misfolded proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

A novel mouse model of veno-occlusive disease provides strategies to prevent thioguanine-induced hepatic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

An intestinal epithelial defect conferring ER stress results in inflammation involving both innate and adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

IL-12 and IL-23: master regulators of innate and adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

The neutrophil NLRC4 inflammasome selectively promotes IL-1β maturation without pyroptosis during acute Salmonella challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

Interleukin-17 and its expanding biological functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000000353

10.1097/MIB.0000000000000353

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25803508%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference